These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 9647138)

  • 1. Activation of hemostasis during cardiopulmonary bypass and pediatric aprotinin dosage.
    Mössinger H; Dietrich W
    Ann Thorac Surg; 1998 Jun; 65(6 Suppl):S45-50; discussion S50-1, S74-6. PubMed ID: 9647138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations.
    Dietrich W; Mössinger H; Spannagl M; Jochum M; Wendt P; Barankay A; Meisner H; Richter JA
    J Thorac Cardiovasc Surg; 1993 Apr; 105(4):712-20. PubMed ID: 7682267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clotting and fibrinolytic disturbance during lung transplantation: effect of low-dose aprotinin. Groningen Lung Transplant Group.
    Gu YJ; de Haan J; Brenken UP; de Boer WJ; Prop J; Van Oeveren W
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):599-606. PubMed ID: 8800145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation.
    Verma YS; Chauhan S; Bisoi AK; Gharde P; Kiran U; Das SN
    Ann Card Anaesth; 2010; 13(2):110-5. PubMed ID: 20442540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose and high-dose aprotinin improve hemostasis in coronary operations.
    Speekenbrink RG; Wildevuur CR; Sturk A; Eijsman L
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):523-30. PubMed ID: 8751522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pump-prime aprotinin dose in cardiac surgery: appraisal of its effects on the hemostatic system.
    Rossi M; Storti S; Martinelli L; Varano C; Marra R; Zamparelli R; Possati G; Schiavello R
    J Cardiothorac Vasc Anesth; 1997 Dec; 11(7):835-9. PubMed ID: 9412880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aprotinin in pediatric cardiac operations: a benefit in complex malformations and with high-dose regimen only.
    Carrel TP; Schwanda M; Vogt PR; Turina MI
    Ann Thorac Surg; 1998 Jul; 66(1):153-8. PubMed ID: 9692456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass.
    Kawasuji M; Ueyama K; Sakakibara N; Tedoriya T; Matsunaga Y; Misaki T; Watanabe Y
    Ann Thorac Surg; 1993 May; 55(5):1205-9. PubMed ID: 7684219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-level-based anticoagulation management during cardiopulmonary bypass: a pilot investigation on the effects of a half-dose aprotinin protocol on postoperative blood loss and hemostatic activation and inflammatory response.
    Koster A; Huebler S; Merkle F; Hentschel T; Gründel M; Krabatsch T; Tambeur L; Praus M; Habazettl H; Kuebler WM; Kuppe H
    Anesth Analg; 2004 Feb; 98(2):285-290. PubMed ID: 14742356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass.
    van Oeveren W; Harder MP; Roozendaal KJ; Eijsman L; Wildevuur CR
    J Thorac Cardiovasc Surg; 1990 May; 99(5):788-96; discussion 796-7. PubMed ID: 1691806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of high- and low-dose aprotinin on activation of hemostasis in open heart operations.
    Dietrich W; Schöpf K; Spannagl M; Jochum M; Braun SL; Meisner H
    Ann Thorac Surg; 1998 Jan; 65(1):70-7; discussion 77-8. PubMed ID: 9456098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss.
    Santamaría A; Mateo J; Oliver A; Litvan H; Murillo J; Souto JC; Fontcuberta J
    Haematologica; 2000 Dec; 85(12):1277-84. PubMed ID: 11114135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose aprotinin reduces activation of hemostasis, allogeneic blood requirement, and duration of postoperative ventilation in pediatric cardiac surgery.
    Mössinger H; Dietrich W; Braun SL; Jochum M; Meisner H; Richter JA
    Ann Thorac Surg; 2003 Feb; 75(2):430-7. PubMed ID: 12607650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of aprotinin on selected parameters of coagulation and drainage blood loss after cardiac operations in patients without coagulation disorders].
    Hirnle T; Stachurski A; Goździk W; Pelczar M; Wachnik J; Hirnle G; Milczarska J; Kustrzycki W
    Pol Merkur Lekarski; 2006 May; 20(119):543-6. PubMed ID: 16875158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is use of aprotinin safe with deep hypothermic circulatory arrest in aortic surgery? Investigations on blood coagulation.
    Okita Y; Takamoto S; Ando M; Morota T; Yamaki F; Kawashima Y
    Circulation; 1996 Nov; 94(9 Suppl):II177-81. PubMed ID: 8901742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low doses of aprotinin in aortocoronary bypass surgery--advantages and disadvantages.
    Golański R; Golański J; Chizyński K; Iwaszkiewicz A; Zasłonka J; Pietrucha T; Chrul S; Watała C
    Med Sci Monit; 2000; 6(4):722-8. PubMed ID: 11208399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aprotinin in coronary operation with cardiopulmonary bypass: does "low-dose" aprotinin inhibit the inflammatory response?
    Englberger L; Kipfer B; Berdat PA; Nydegger UE; Carrel TP
    Ann Thorac Surg; 2002 Jun; 73(6):1897-904. PubMed ID: 12078788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of minimal-dose aprotinin on coronary artery bypass grafting.
    Hayashida N; Isomura T; Sato T; Maruyama H; Kosuga K; Aoyagi S
    J Thorac Cardiovasc Surg; 1997 Aug; 114(2):261-9. PubMed ID: 9270645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing thrombin formation during cardiopulmonary bypass: is there a benefit of the additional anticoagulant action of aprotinin?
    Dietrich W
    J Cardiovasc Pharmacol; 1996; 27 Suppl 1():S50-7. PubMed ID: 8938284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nafamostat mesilate and minimal-dose aprotinin on blood-foreign surface interactions in cardiopulmonary bypass.
    Kaminishi Y; Hiramatsu Y; Watanabe Y; Yoshimura Y; Sakakibara Y
    Ann Thorac Surg; 2004 Feb; 77(2):644-50. PubMed ID: 14759453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.